Table II.
Parameter | LVNC (n= 13) | Controls (n = 10) | P-value |
---|---|---|---|
Non-compacted segments per patient: | |||
Mean (SD) | 6.7 (1.8) | 0.0 (0.0) | – |
Range (min.–max.) | 4.0–10.0 | 0.0–0.0 | |
Non-compacted/compacted ratio: | |||
Mean (SD) | 4.0 (1.7) | 0.0 (0.0) | – |
Range (min.–max.) | 2.5–9.0 | 0.0–0.0 | |
LV end-diastolic diameter: | 0.0004 | ||
Mean (SD) | 64.5 (9.4) | 52.6 (3.3) | |
Range (min.–max.) | 55.0–80.0 | 47.0–56.0 | |
LV end-diastolic volume: | 0.0001 | ||
Mean (SD) | 269.5 (143.3) | 138.1 (13.9) | |
Range (min.–max.) | 160.0–655.0 | 120.0–160.0 | |
LV end-systolic volume: | 0.0001 | ||
Mean (SD) | 190.3 (143.5) | 52.4 (8.7) | |
Range (min.–max.) | 70.0–525.0 | 40.0–72.0 | |
LV ejection fraction: | 0.0003 | ||
Mean (SD) | 36.1 (17.9) | 61.0 (5.1) | |
Range (min.–max.) | 11.0–66.0 | 55.0–69.0 | |
LGE presence | 9 (69.2%) | 0 (0.0%) | 0.0007 |
Data are expressed as mean ± SD, range and n (%). Bold text indicates a significant p-value of < 0.05. LVNC – left ventricular non-compaction, LGE – late gadolinium enhancement, LV – left ventricle.